{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:09:37Z","timestamp":1785409777409,"version":"3.56.0"},"posted":{"date-parts":[[2026,1,23]]},"group-title":"Neuroscience","reference-count":54,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"name":"NIH","award":["T32MH112510"],"award-info":[{"award-number":["T32MH112510"]}]},{"name":"NIH","award":["RF1AG075901"],"award-info":[{"award-number":["RF1AG075901"]}]},{"name":"NIH","award":["5R01MH104610"],"award-info":[{"award-number":["5R01MH104610"]}]},{"name":"NIH","award":["R01MH085802"],"award-info":[{"award-number":["R01MH085802"]}]},{"id":[{"id":"https:\/\/ror.org\/00e7vz537","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014370","name":"Simons Foundation Autism Research Initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014370","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Rett syndrome (RTT), a severe neurodevelopmental disorder caused by mutations in MECP2, leads to profound synaptic and circuit deficits in the brain. While neurons have historically been the focus of RTT pathology, emerging evidence implicates astrocytes in non-cell autonomous mechanisms that impair synaptic structure, function and development. Here, we uncover a central role for astrocyte-secreted IGFBP2 in mediating these deficits and demonstrate that treatment with an IGF1-derived peptide restores synapse formation by promoting IGFBP2 degradation. Using an indirect astrocyte-neuron co-culture system, we show that astrocytes derived from RTT model mice suppress excitatory synapse formation in wild-type neurons and that this impairment is reversed when RTT astrocytes are treated with IGF1(1-3) peptide. Proteomic analysis reveals elevated levels of IGFBP2 in RTT astrocytes and their conditioned media. IGF1(1-3) peptide treatment leads to proteasomal degradation of IGFBP2, increasing IGF1 bioavailability, restoring mitochondrial function, and enhancing downstream PI3K\/Akt signaling in neurons. Our data define a molecular mechanism by which astrocyte dysfunction in RTT can be rescued and provide a mechanistic basis for the therapeutic efficacy of IGF1(1-3) peptide, including Trofinetide, an FDA-approved IGF1 peptide mimetic, in RTT.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Significance Statement<\/jats:title>\n                  <jats:p>Astrocyte dysfunction is increasingly recognized as a contributor to neurodevelopmental disorders, yet their precise mechanisms of action remain elusive. Here, we identify IGFBP2 as a key astrocyte-derived inhibitor of synaptogenesis in Rett syndrome. We show that an IGF1-derived peptide, IGF1(1-3), depletes IGFBP2 via proteasomal degradation. This restores IGF1 bioavailability and rescues synaptic function in a non-cell-autonomous manner. These findings provide a mechanistic explanation for the clinical efficacy of IGF1 peptide and its mimetics in Rett syndrome, and highlight astrocytes as rational therapeutic targets in neurodevelopmental and other disorders.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.01.22.701190","type":"posted-content","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:00:12Z","timestamp":1769180412000},"source":"Crossref","is-referenced-by-count":0,"title":["IGF1 peptide targets Rett Syndrome astrocytes to degrade IGF binding protein, rescue synaptogenesis and restore mitochondrial function"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-7104","authenticated-orcid":false,"given":"Prachi","family":"Ojha","sequence":"first","affiliation":[{"name":"The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velina","family":"Kozareva","sequence":"additional","affiliation":[{"name":"Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Barlowe","sequence":"additional","affiliation":[{"name":"The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Schulte","sequence":"additional","affiliation":[{"name":"Whitehead Institute for Biomedical Research, Quantitative Proteomics Core, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby Minh","family":"Lam","sequence":"additional","affiliation":[{"name":"The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle L","family":"Tomasello","sequence":"additional","affiliation":[{"name":"Whitehead Institute for Biomedical Research, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Fraenkel","sequence":"additional","affiliation":[{"name":"Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Jaenisch","sequence":"additional","affiliation":[{"name":"Whitehead Institute for Biomedical Research, Cambridge, MA, USA"},{"name":"Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mriganka","family":"Sur","sequence":"additional","affiliation":[{"name":"The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA"},{"name":"Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026071501100598000_2026.01.22.701190v2.1","doi-asserted-by":"publisher","DOI":"10.1038\/13810"},{"key":"2026071501100598000_2026.01.22.701190v2.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.10.001"},{"key":"2026071501100598000_2026.01.22.701190v2.3","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3434"},{"key":"2026071501100598000_2026.01.22.701190v2.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3897"},{"key":"2026071501100598000_2026.01.22.701190v2.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-018-0006-3"},{"key":"2026071501100598000_2026.01.22.701190v2.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-025-00926-1"},{"key":"2026071501100598000_2026.01.22.701190v2.7","doi-asserted-by":"publisher","DOI":"10.1126\/science.1153252"},{"key":"2026071501100598000_2026.01.22.701190v2.8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1505909112"},{"key":"2026071501100598000_2026.01.22.701190v2.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2024.04.007"},{"key":"2026071501100598000_2026.01.22.701190v2.10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1138389"},{"key":"2026071501100598000_2026.01.22.701190v2.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610593104"},{"key":"2026071501100598000_2026.01.22.701190v2.12","doi-asserted-by":"publisher","DOI":"10.1038\/nn1689"},{"key":"2026071501100598000_2026.01.22.701190v2.13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812394106"},{"key":"2026071501100598000_2026.01.22.701190v2.14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1311685111"},{"key":"2026071501100598000_2026.01.22.701190v2.15","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e32835f19a7"},{"key":"2026071501100598000_2026.01.22.701190v2.16","first-page":"34","article-title":"Rett syndrome: genes, synapses, circuits, and therapeutics","volume":"3","year":"2012","journal-title":"Front Psychiatry"},{"key":"2026071501100598000_2026.01.22.701190v2.17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy323"},{"key":"2026071501100598000_2026.01.22.701190v2.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02398-1"},{"key":"2026071501100598000_2026.01.22.701190v2.19","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.medj.2024.05.018","article-title":"Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study","volume":"5","year":"2024","journal-title":"Med"},{"key":"2026071501100598000_2026.01.22.701190v2.20","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1097\/MS9.0000000000001896","article-title":"Trofinetide receives FDA approval as first drug for Rett syndrome","volume":"86","year":"2024","journal-title":"Annals of Medicine and Surgery"},{"key":"2026071501100598000_2026.01.22.701190v2.21","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu008"},{"key":"2026071501100598000_2026.01.22.701190v2.22","doi-asserted-by":"crossref","unstructured":"E. Albizzati , et al., Mecp2 knock-out astrocytes affect synaptogenesis by interleukin 6 dependent mechanisms. iScience 27 (2024).","DOI":"10.1016\/j.isci.2024.109296"},{"key":"2026071501100598000_2026.01.22.701190v2.23","doi-asserted-by":"crossref","first-page":"111386","DOI":"10.1016\/j.brainresbull.2025.111386","article-title":"Interpreting the rich dialogue between astrocytes and neurons: An overview in Rett syndrome","volume":"227","year":"2025","journal-title":"Brain Res Bull"},{"key":"2026071501100598000_2026.01.22.701190v2.24","doi-asserted-by":"publisher","DOI":"10.1038\/nn.2275"},{"key":"2026071501100598000_2026.01.22.701190v2.25","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0324-09.2009"},{"key":"2026071501100598000_2026.01.22.701190v2.26","doi-asserted-by":"publisher","DOI":"10.1038\/nature10214"},{"key":"2026071501100598000_2026.01.22.701190v2.27","doi-asserted-by":"crossref","first-page":"20565","DOI":"10.1038\/s41598-024-71040-y","article-title":"Mitochondrial dysfunction and increased reactive oxygen species production in MECP2 mutant astrocytes and their impact on neurons","volume":"14","year":"2024","journal-title":"Scientific Reports"},{"key":"2026071501100598000_2026.01.22.701190v2.28","doi-asserted-by":"crossref","first-page":"111942","DOI":"10.1016\/j.celrep.2022.111942","article-title":"Mutations in the transcriptional regulator MeCP2 severely impact key cellular and molecular signatures of human astrocytes during maturation","volume":"42","year":"2023","journal-title":"Cell Rep"},{"key":"2026071501100598000_2026.01.22.701190v2.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01150-1"},{"key":"2026071501100598000_2026.01.22.701190v2.30","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnad008"},{"key":"2026071501100598000_2026.01.22.701190v2.31","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-0033"},{"key":"2026071501100598000_2026.01.22.701190v2.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605652103"},{"key":"2026071501100598000_2026.01.22.701190v2.33","doi-asserted-by":"publisher","DOI":"10.1080\/08977194.2016.1191480"},{"key":"2026071501100598000_2026.01.22.701190v2.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.12.001"},{"key":"2026071501100598000_2026.01.22.701190v2.35","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010147"},{"key":"2026071501100598000_2026.01.22.701190v2.36","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-024-01974-1"},{"key":"2026071501100598000_2026.01.22.701190v2.37","doi-asserted-by":"publisher","DOI":"10.1038\/nn0309-239"},{"key":"2026071501100598000_2026.01.22.701190v2.38","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-014-8295-9"},{"key":"2026071501100598000_2026.01.22.701190v2.39","first-page":"6154080","article-title":"Developmental Dynamics of Rett Syndrome","volume":"2016","year":"2016","journal-title":"Neural Plast"},{"key":"2026071501100598000_2026.01.22.701190v2.40","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.620859"},{"key":"2026071501100598000_2026.01.22.701190v2.41","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.3390\/ijms20153813","article-title":"Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome","volume":"20","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026071501100598000_2026.01.22.701190v2.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2006.09.037"},{"key":"2026071501100598000_2026.01.22.701190v2.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2005.12.027"},{"key":"2026071501100598000_2026.01.22.701190v2.44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1086446"},{"key":"2026071501100598000_2026.01.22.701190v2.45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00001756-199901180-00031","article-title":"Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro","volume":"10","year":"1999","journal-title":"Neuroreport"},{"key":"2026071501100598000_2026.01.22.701190v2.46","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00338-8"},{"key":"2026071501100598000_2026.01.22.701190v2.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.12.020"},{"key":"2026071501100598000_2026.01.22.701190v2.48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1104977108"},{"key":"2026071501100598000_2026.01.22.701190v2.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2012.05.029"},{"key":"2026071501100598000_2026.01.22.701190v2.50","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.825063"},{"key":"2026071501100598000_2026.01.22.701190v2.51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1615330113"},{"key":"2026071501100598000_2026.01.22.701190v2.52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.046847"},{"key":"2026071501100598000_2026.01.22.701190v2.53","doi-asserted-by":"publisher","DOI":"10.1016\/0387-7604(93)90045-A"},{"key":"2026071501100598000_2026.01.22.701190v2.54","first-page":"58","article-title":"Mitochondrial Dysfunction in the Pathogenesis of Rett Syndrome: Implications for Mitochondria-Targeted Therapies","volume":"11","year":"2017","journal-title":"Front Cell Neurosci"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.01.22.701190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:10:17Z","timestamp":1784103017000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.01.22.701190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":54,"URL":"https:\/\/doi.org\/10.64898\/2026.01.22.701190","relation":{},"subject":[],"published":{"date-parts":[[2026,1,23]]},"subtype":"preprint"}}